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Swine as a Potential Reservoir of Shiga
Toxin-Producing Escherichia coli
O157:H7 in Japan
To the Editor: Shiga toxin-producing Escheri-
chia coli (STEC) O157:H7 has become a major
meat safety issue worldwide. Cattle, an
important reservoir of human infection (1), may
not be the only source of this organism (2,3). In a
survey of pigs in England (4), non-STEC O157
was isolated from four (0.4%) fecal samples
collected (after slaughter) from 1,000 pigs. We
found that, although an unlikely source of
infection for humans, pigs are a potential
reservoir of STEC O157:H7 in Japan.
In 1997, there were 14,400 pig farms and
9,823,000 pigs (average 682 per farm) in Japan.
Thirty-five (0.24%) of these farms were randomly
selected for study, and rectal swabs were taken
from 221 healthy pigs during May and June
1997. The average number of animals examined
on each farm was 6.3.
Fecal samples were dipped into test tubes
containing Cary-Blair transport medium (Nissui,
Japan) and kept refrigerated until processing
(usually within 48 hours). Swabs were then
incubated overnight at 42°C in 10 ml of mEC
broth (Kyokuto, Japan) containing 20 µg/ml of
novobiocin (Sigma, USA), after which one loop of
the broth was spread onto MacConkey sorbitol
agar medium (Difco, USA). After overnight
incubation at 37°C, sorbitol-negative colonies
from the agar plates were tested by slide
agglutination with E. coli O157-latex test (Oxoid,
UK). Strains that agglutinated were confirmed
as  E. coli by using the API 20E system
(BioMerieux, France). Strains confirmed as
E. coli O157 were subcultured in a motility
medium for 3 to 4 days to enhance development
of flagella, then they were tested by tube
agglutination with E. coli H7 antiserum (Denka-
seiken, Japan). The swine E. coli O157:H7
isolates were examined by polymerase chain
reaction for the presence of Shiga-toxin genes
stx1 and stx2 and to elucidate intimin (eaeA)
DNA sequences (5), for a plasmid of 92 kb
(pO157) by agarose gel electrophoresis (6), and
for phage type by the previously described
method (7).
Although the numbers sampled were too
small to allow comparisons between farms,
samples from three (1.4%) apparently healthy
pigs (ages: 2, 6, and 9 months) from three farms
(8.6%) were positive for STEC O157:H7. The
three strains from the pigs were biochemically
typical of STEC O157:H7 that did not ferment
sorbitol and lacked ß-glucuronidase; aggluti-
nated with E. coli O157-latex and with H7
antiserum; possessed stx1, stx2, and eaeA genes;
and harbored pO157 plasmid characteristic of
STEC O157:H7. The strains belonged to phage
type 21, 37, or 43.
The 1.4% carriage rate of STEC O157:H7 in
pigs in this investigation is almost the same as
that in cattle in Japan (8), which suggests that
STEC O157:H7 strains are probably widespread
in Japanese pig populations. The STEC O157-
positive pigs were each housed in a concrete-
floored pen and kept separate from cattle.
Whether these pig isolates are the same as
cattle or human isolates needs to be clarified;
however, they had the same biochemical and
genetic markers as STEC O157:H7 isolated
from cattle and humans (6,9). The phage type
21 that we found among pig isolates was also
observed in bovine and human STEC O157:H7
isolates in Japan (7). These results suggest
that common vehicles for dissemination of the
organism may exist.
So far, pork has not been identified as a
source of human STEC O157:H7 illness in
industrialized countries, but our results indicate
that eating pork, contact with pigs, and
contamination with pig feces should be
considered potential sources of this pathogen.
This is the first isolation of naturally occurring
STEC O157:H7 in pigs in Japan.
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Hospitalizations for Rotavirus
Gastroenteritis in Gipuzkoa (Basque
Country), Spain
To the Editor: Rotavirus is the main cause of
severe acute gastroenteritis among children both
in developing and in industrialized countries.
The incidence of rotavirus gastroenteritis in
northern Europe is similar to or greater than the
estimated incidence of the disease in the United
States (1-3); however, little is known about the
impact of rotavirus infection on health in
southern Europe.
We examined the incidence of hospitalization
for rotavirus gastroenteritis during 3 years (July
1993-June 1996) in Gipuzkoa (population
400,480, of whom 58,896 are <15 years of age).
The presence of rotavirus antigen was prospec-
tively investigated by enzyme immunoanalysis
(IDEIA Rotavirus, Dako Diagnostics, UK) in
stool samples from all patients <15 years of age in
the study area for whom a microbiologic analysis
was requested for acute gastroenteritis. Chil-
dren hospitalized for rotavirus gastroenteritis
were sought retrospectively through searching
both the computerized records of microbiology
laboratory and hospital medical records for the
diagnoses 558.9 (other gastroenteritis and
presumably noninfectious colitis) and 008.6-
009.3 (enteritis due to specific viruses and
presumably infectious intestinal disorders) (4).
All children in this study lived in the study area,
had been hospitalized for gastroenteritis, and
had one stool sample positive for rotavirus in the
first 5 days of hospitalization without another
gastroenteritis agent detected in the stool.
One hundred fifty-two (82 male and 70
female) of 1,004 children <15 years of age with
rotavirus gastroenterititis had been hospitalized
for rotavirus infection. No deaths were recorded.
Cases usually occurred in epidemic waves, with
the highest incidence in January-March. An
additional 133 children with rotavirus in stools
had been hospitalized but were not included in
this study because they had hospital-acquired
infections (67 cases), were coinfected by another
microorganism (11 cases), came from outside the
geographic study area (19 cases), or had a main
reason for hospitalization other than gastroen-
teritis (36 cases). The mean annual incidence of
hospitalization was 0.86 per 1,000 children
(1 month to 14 years old) and 3.11 per 1,000
children (1 month to 5 years old). The maximum
incidence occurred in 6- to 11-month-old children
(11.81 per 1,000 children). Children were
hospitalized for a mean of 4.8 ± 2.2 days.
Rotavirus gastroenteritis was responsible for 152
(2%) of 7,403 pediatric admissions. For the 1- to
35-month age group, community-acquired
rotavirus gastroenteritis was responsible for 140
(4.6%) of 3,026 admissions.
Although the incidence is based solely on
confirmed cases, the findings closely reflect
disease incidence in our region. The National
System of Health covers 100% of the reference
population, and hospitalization of children in
private institutions is rare. Stool cultures were
taken for most children for gastroenteritis
(94.5%), and the presence of rotavirus was
investigated in every case.
The hospitalization rate observed in this
study was similar to that reported in other
studies from Sweden (2), Denmark (5), and the
United States (6) and lower than that found in
England and Wales (3). In Spain, reporting of
rotavirus infection is not required, is not
included in mortality registers, and is not the
object of specific vigilance by sentinel surveil-
lance systems. Therefore, information about the
incidence and impact of rotavirus infection in
Spain is scarce. However, two reports from Spain
must be highlighted: one is based on a theoretical
prediction using a statistical model (7) and the